Acard in pregnancy

Acard in pregnancy-when to use?

Acard has recently become a drug that is taken by more and more pregnant women. This is due to the increase in the availability of ultrasounds and the popularity of the PAPP-A test. This is because, contrary to earlier reports, it is not only used to assess the risk of chromosomal aberrations. Thanks to the examination in the first trimester, which evaluates, in addition to ultrasound, biochemical markers, also the mean arterial pressure or flow in the uterine arteries, it is possible to assess the woman’s risk of pre-eclampsia (preeclampsia) or fetal growth restriction. Modern medicine, in addition to early detection of the aforementioned risks, makes widespread use of prevention. This is done with acetylsalicylic acid (Acard) at a dose of 150 mg.

It is important to take Acard as prescribed by your doctor. It is most often prescribed to expectant mothers with a risk of pre-eclampsia or fetal growth restriction greater than 1:150. Prophylaxis should be started before the age of 16. Week and it continues until the 36th. One week of pregnancy. Statistically, the use of Acard reduces the risk of preeclampsia before 34. week of pregnancy by 80%.

Acard in pregnancy- side effects

Every drug has its side effects. However, it is used because the benefits outweigh the risks. The symptoms that moms-to-be who use Acard during pregnancy most often complain about are:

• Heartburn
• Nausea
• Abdominal pain
• Transient liver dysfunction
• Bleeding

However, it is important to be aware of the consequences of the negative conditions that taking acetylsalicylic acid daily is supposed to protect us from. Pre-eclampsia can carry dangerous complications for both the mother-to-be and the baby.

Read more
:  Pre-eclampsia in pregnancy

Acard in pregnancy-is it safe?

Acard, or acetylsalicylic acid, is classified as a non-steroidal anti-inflammatory drug. Until recently, it was thought that these drugs should not be used during pregnancy due to, among other things. The risk of fetal heart and facial defects or premature closure of the Botall’s duct.  Reports in recent years, however, declare that the risk is low at low doses, the kind used for the prevention of pre-eclampsia. The position that paracetamol remains the first choice for analgesic and antipyretic treatment in pregnancy remains valid.